Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Gixam's Efficacy Predicting the Presence of Advanced and Non-advanced Colorectal Neoplasia in a FIT Negative Population

NCT07623902 is registered in ClinicalTrials.gov with Jubaan Ltd. as lead sponsor.

NCT NCT07623902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07623902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Gixam's Efficacy Predicting the Presence of Advanced and Non-advanced Colorectal Neoplasia in a FIT Negative Population
Lead sponsor
Jubaan Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
May 18, 2026
Completion date
December 31, 2026
Enrollment
1,436 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

crc screening, microbiome